vs
Mativ Holdings, Inc.（MATV）与West Pharmaceutical Services（WST）财务数据对比。点击上方公司名可切换其他公司
West Pharmaceutical Services的季度营收约是Mativ Holdings, Inc.的1.7倍（$805.0M vs $463.1M），Mativ Holdings, Inc.净利率更高（21.8% vs 16.4%，领先5.4%），West Pharmaceutical Services同比增速更快（7.5% vs 1.0%），West Pharmaceutical Services自由现金流更多（$175.0M vs $8.0M），过去两年West Pharmaceutical Services的营收复合增速更高（7.6% vs -3.8%）
Mativ Holdings是一家全球特种材料制造商，主要生产高性能先进聚合物、无纺布、过滤解决方案及功能性涂层材料，服务医疗、工业、消费品、航空航天、能源等领域，业务遍及北美、欧洲及亚太地区。
美国West Pharmaceutical Services是注射用药品包装及给药系统的设计和制造商，1923年成立，总部位于宾夕法尼亚州埃克斯顿。成立初期主营注射类药物包装用橡胶组件，曾为青霉素和胰岛素生产商提供符合无菌要求的配套产品。
MATV vs WST — 直观对比
营收规模更大
WST
是对方的1.7倍
$463.1M
营收增速更快
WST
高出6.5%
1.0%
净利率更高
MATV
高出5.4%
16.4%
自由现金流更多
WST
多$167.0M
$8.0M
两年增速更快
WST
近两年复合增速
-3.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $463.1M | $805.0M |
| 净利润 | $100.8M | $132.1M |
| 毛利率 | 18.8% | 37.8% |
| 营业利润率 | 2.2% | 19.5% |
| 净利率 | 21.8% | 16.4% |
| 营收同比 | 1.0% | 7.5% |
| 净利润同比 | 6620.0% | 1.5% |
| 每股收益（稀释后） | $1.87 | $1.82 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MATVWST
| Q4 25 | $463.1M | $805.0M | ||
| Q3 25 | $513.7M | $804.6M | ||
| Q2 25 | $525.4M | $766.5M | ||
| Q1 25 | $484.8M | $698.0M | ||
| Q4 24 | $458.6M | $748.8M | ||
| Q3 24 | $498.5M | $746.9M | ||
| Q2 24 | $523.8M | $702.1M | ||
| Q1 24 | $500.2M | $695.4M |
净利润MATVWST
| Q4 25 | $100.8M | $132.1M | ||
| Q3 25 | $-3.2M | $140.0M | ||
| Q2 25 | $-9.5M | $131.8M | ||
| Q1 25 | $-425.5M | $89.8M | ||
| Q4 24 | $1.5M | $130.1M | ||
| Q3 24 | $-20.8M | $136.0M | ||
| Q2 24 | $-1.4M | $111.3M | ||
| Q1 24 | $-28.0M | $115.3M |
毛利率MATVWST
| Q4 25 | 18.8% | 37.8% | ||
| Q3 25 | 19.3% | 36.6% | ||
| Q2 25 | 19.7% | 35.7% | ||
| Q1 25 | 15.0% | 33.2% | ||
| Q4 24 | 16.9% | 36.5% | ||
| Q3 24 | 18.8% | 35.4% | ||
| Q2 24 | 20.8% | 32.8% | ||
| Q1 24 | 16.8% | 33.1% |
营业利润率MATVWST
| Q4 25 | 2.2% | 19.5% | ||
| Q3 25 | 3.1% | 20.8% | ||
| Q2 25 | 3.8% | 20.1% | ||
| Q1 25 | -88.8% | 15.3% | ||
| Q4 24 | 0.6% | 21.3% | ||
| Q3 24 | 1.4% | 21.6% | ||
| Q2 24 | 2.0% | 18.0% | ||
| Q1 24 | -2.8% | 17.7% |
净利率MATVWST
| Q4 25 | 21.8% | 16.4% | ||
| Q3 25 | -0.6% | 17.4% | ||
| Q2 25 | -1.8% | 17.2% | ||
| Q1 25 | -87.8% | 12.9% | ||
| Q4 24 | 0.3% | 17.4% | ||
| Q3 24 | -4.2% | 18.2% | ||
| Q2 24 | -0.3% | 15.9% | ||
| Q1 24 | -5.6% | 16.6% |
每股收益（稀释后）MATVWST
| Q4 25 | $1.87 | $1.82 | ||
| Q3 25 | $-0.06 | $1.92 | ||
| Q2 25 | $-0.18 | $1.82 | ||
| Q1 25 | $-7.82 | $1.23 | ||
| Q4 24 | $0.03 | $1.78 | ||
| Q3 24 | $-0.38 | $1.85 | ||
| Q2 24 | $-0.03 | $1.51 | ||
| Q1 24 | $-0.52 | $1.55 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $84.2M | $791.3M |
| 总债务越低越好 | $1.0B | $202.8M |
| 股东权益账面价值 | $498.7M | $3.2B |
| 总资产 | $2.1B | $4.3B |
| 负债/权益比越低杠杆越低 | 2.07× | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资MATVWST
| Q4 25 | $84.2M | $791.3M | ||
| Q3 25 | $97.1M | $628.5M | ||
| Q2 25 | $95.6M | $509.7M | ||
| Q1 25 | $84.0M | $404.2M | ||
| Q4 24 | $94.3M | $484.6M | ||
| Q3 24 | $162.2M | $490.9M | ||
| Q2 24 | $133.4M | $446.2M | ||
| Q1 24 | $128.9M | $601.8M |
总债务MATVWST
| Q4 25 | $1.0B | $202.8M | ||
| Q3 25 | $1.0B | $202.7M | ||
| Q2 25 | $1.1B | $202.6M | ||
| Q1 25 | $1.1B | $202.6M | ||
| Q4 24 | $1.1B | $202.6M | ||
| Q3 24 | $1.2B | $202.6M | ||
| Q2 24 | $1.2B | $205.8M | ||
| Q1 24 | $1.2B | $206.2M |
股东权益MATVWST
| Q4 25 | $498.7M | $3.2B | ||
| Q3 25 | $397.4M | $3.1B | ||
| Q2 25 | $416.6M | $2.9B | ||
| Q1 25 | $428.2M | $2.7B | ||
| Q4 24 | $858.5M | $2.7B | ||
| Q3 24 | $882.3M | $2.8B | ||
| Q2 24 | $898.0M | $2.6B | ||
| Q1 24 | $906.9M | $2.7B |
总资产MATVWST
| Q4 25 | $2.1B | $4.3B | ||
| Q3 25 | $2.0B | $4.1B | ||
| Q2 25 | $2.1B | $4.0B | ||
| Q1 25 | $2.1B | $3.6B | ||
| Q4 24 | $2.4B | $3.6B | ||
| Q3 24 | $2.6B | $3.7B | ||
| Q2 24 | $2.6B | $3.5B | ||
| Q1 24 | $2.7B | $3.6B |
负债/权益比MATVWST
| Q4 25 | 2.07× | 0.06× | ||
| Q3 25 | 2.63× | 0.07× | ||
| Q2 25 | 2.66× | 0.07× | ||
| Q1 25 | 2.67× | 0.08× | ||
| Q4 24 | 1.30× | 0.08× | ||
| Q3 24 | 1.32× | 0.07× | ||
| Q2 24 | 1.29× | 0.08× | ||
| Q1 24 | 1.30× | 0.08× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.3M | $251.1M |
| 自由现金流经营现金流 - 资本支出 | $8.0M | $175.0M |
| 自由现金流率自由现金流/营收 | 1.7% | 21.7% |
| 资本支出强度资本支出/营收 | 2.4% | 9.5% |
| 现金转化率经营现金流/净利润 | 0.19× | 1.90× |
| 过去12个月自由现金流最近4个季度 | $93.8M | $468.9M |
8季度趋势，按日历期对齐
经营现金流MATVWST
| Q4 25 | $19.3M | $251.1M | ||
| Q3 25 | $72.8M | $197.2M | ||
| Q2 25 | $57.6M | $177.1M | ||
| Q1 25 | $-15.9M | $129.4M | ||
| Q4 24 | $24.1M | $190.1M | ||
| Q3 24 | $37.6M | $180.1M | ||
| Q2 24 | $46.1M | $165.0M | ||
| Q1 24 | $-13.0M | $118.2M |
自由现金流MATVWST
| Q4 25 | $8.0M | $175.0M | ||
| Q3 25 | $66.7M | $133.9M | ||
| Q2 25 | $48.9M | $101.9M | ||
| Q1 25 | $-29.8M | $58.1M | ||
| Q4 24 | $2.0M | $85.2M | ||
| Q3 24 | $25.5M | $98.8M | ||
| Q2 24 | $37.4M | $64.8M | ||
| Q1 24 | $-25.1M | $27.6M |
自由现金流率MATVWST
| Q4 25 | 1.7% | 21.7% | ||
| Q3 25 | 13.0% | 16.6% | ||
| Q2 25 | 9.3% | 13.3% | ||
| Q1 25 | -6.1% | 8.3% | ||
| Q4 24 | 0.4% | 11.4% | ||
| Q3 24 | 5.1% | 13.2% | ||
| Q2 24 | 7.1% | 9.2% | ||
| Q1 24 | -5.0% | 4.0% |
资本支出强度MATVWST
| Q4 25 | 2.4% | 9.5% | ||
| Q3 25 | 1.2% | 7.9% | ||
| Q2 25 | 1.7% | 9.8% | ||
| Q1 25 | 2.9% | 10.2% | ||
| Q4 24 | 4.8% | 14.0% | ||
| Q3 24 | 2.4% | 10.9% | ||
| Q2 24 | 1.7% | 14.3% | ||
| Q1 24 | 2.4% | 13.0% |
现金转化率MATVWST
| Q4 25 | 0.19× | 1.90× | ||
| Q3 25 | — | 1.41× | ||
| Q2 25 | — | 1.34× | ||
| Q1 25 | — | 1.44× | ||
| Q4 24 | 16.07× | 1.46× | ||
| Q3 24 | — | 1.32× | ||
| Q2 24 | — | 1.48× | ||
| Q1 24 | — | 1.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MATV
| Other | $208.7M | 45% |
| SAS Segment | $157.4M | 34% |
| FAM Segment | $97.0M | 21% |
WST
| Proprietary Products | $661.8M | 82% |
| Contract Manufactured Products | $143.2M | 18% |
| Affiliated Entity | $3.3M | 0% |
